7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study

Roberto Persiani, Alberto Biondi, Domenico D'Ugo, Stefano Rausei, Carmelo Pozzo, Carlo Antonio Barone, Ferdinando Carlo Maria Cananzi, Giovanni Schinzari

Risultato della ricerca: Contributo in rivistaArticolo in rivista

11 Citazioni (Scopus)

Abstract

Perioperative chemotherapy is considered an effective treatment option for patients with gastric carcinoma. We report the results after a 7-year follow-up of a study aimed at evaluating a perioperative chemotherapy protocol in a group of patients with locally advanced gastric cancer (LAGC).
Lingua originaleEnglish
pagine (da-a)2146-2152
Numero di pagine7
RivistaAnnals of Surgical Oncology
Volume15
DOI
Stato di pubblicazionePubblicato - 2008

Keywords

  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols
  • Cisplatin
  • Epirubicin
  • Etoposide
  • Female
  • Gastrectomy
  • Glucuronates
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Perioperative Care
  • Stomach Neoplasms
  • Survival Rate
  • Time Factors
  • Treatment Outcome

Fingerprint Entra nei temi di ricerca di '7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study'. Insieme formano una fingerprint unica.

Cita questo